Israeli pharmaceutical company bought for $1.1B by Mitsubishi Tanabe Pharma

Le canadien Valeant Pharmaceuticals International Inc. a annoncé un accord dimanche pour le rachat du groupe américain Salix Pharmaceuticals Ltd., spécialisé dans les traitements gastro-intestinaux
Joel Saget (AFP/Archives)

Israeli pharmaceutical company Neuroderm has been bought out in a massive deal for $1.1 billion by Japan's Mitsubishi Tanabe Pharma Corp, the company announced on Monday.

The all-cash deal will expand the company's business overseas, according to Reuters.

NeuroDerm develops drugs and medical devices for central nervous system (CNS) disorders such as Parkinson's, in which it was the first to develop a key treatment currently used for the disease.

According to the company's website, they are a clinical-stage pharmaceutical company developing "next-generation treatments."


8Previous articleEU files antitrust charges against Israeli pharmaceutical giant Teva
8Next articleUS sees strong job creation in July as unemployment falls